CompaniesMonogram Biosciences

Monogram Biosciences

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

40

By Phase

PHASE1: 1

By Status

NOT_YET_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2024

2025

2026

2027

2028

2029

Today

Hover over trial bars to see details

Recent Trials

NCT06987318Collaborator

A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

PHASE1Not yet recruiting

40 participants

Started: Oct 15, 2025 · Completed: May 7, 2028

Funding History (20)

8-K

Aug 10, 2009

8-K

Jun 24, 2009

8-K

May 6, 2009

8-K

Feb 12, 2009

8-K

Jan 20, 2009

8-K

Dec 9, 2008

DEF 14A

Nov 19, 2008

8-K

Nov 4, 2008

8-K

Oct 27, 2008

8-K

Oct 3, 2008